Dr. Reddy’s Laboratories Ltd ADR share price logo

Dr. Reddy’s Laboratories Ltd ADR

NYSE: RDY

Large Cap

$13.27

-0.08

(-0.60%)

as on

Dr. Reddy’s Laboratories Ltd ADR Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $13.21
    $13.38
    downward going graph

    0.45%

    Downside

    0.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $12.77
    $16.17
    downward going graph

    3.77%

    Downside

    21.85%

    Upside

    downward going graph

Dr. Reddy’s Laboratories Ltd ADR share price movements today

Previous Close
$13.35
Open
$13.35
Volume
1.9M
Day's Low - High
$13.21 - $13.38
52 Week Low - High
$12.77 - $16.17

Dr. Reddy’s Laboratories Ltd ADR Historical Returns

1 Month Return
+ 1.6 %
3 Month Return
-5.18 %
1 Year Return
-1.18 %
3 Year Return
+ 9.82 %
5 Year Return
-5.57 %

Dr. Reddy’s Laboratories Ltd ADR Stock Fundamentals & Key Indicators

Check Dr. Reddy’s Laboratories Ltd ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.5B

EPS (TTM)

56.33

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.14%

PE Ratio (TTM)

19.06

Industry PE ratio

23.37857142857143

PEG Ratio

3.7968

EBITDA

84.8B

Revenue (TTM)

345.8B

Profit Margin

16.36%

Return On Equity TTM

16.10%

Dr. Reddy’s Laboratories Ltd ADR Stock Valuation

Track how Dr. Reddy’s Laboratories Ltd ADR P/E has moved over time to understand its valuation trends.

Dr. Reddy’s Laboratories Ltd ADR in the last 5 years

  • Overview

  • Trends

Lowest (0.04x)

June 30, 2024

Today (19.06x)

May 6, 2026

Industry (23.38x)

May 6, 2026

Highest (8.91x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 19.06x

Dr. Reddy’s Laboratories Ltd ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dr. Reddy’s Laboratories Ltd ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Dr. Reddy’s Laboratories Ltd ADR image
Dr. Reddy’s Laboratories Ltd ADR
BUY$11.5B-5.57%19.0616.36%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$24.7BNA20.8841.94%
Viatris Inc image
Viatris Inc
HOLD$17.5B9.12%NA-24.58%
Haleon plc image
Haleon plc
BUY$41.0BNA18.8615.11%
Zoetis Inc image
Zoetis Inc
BUY$47.6B-32.74%18.7228.24%

Stock Returns calculator for Dr. Reddy’s Laboratories Ltd ADR Stock including INR - Dollar returns

The Dr. Reddy’s Laboratories Ltd ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dr. Reddy’s Laboratories Ltd ADR investment value today

Current value as on today

₹1,11,024

Returns

₹11,024

(+11.02%)

Returns from Dr. Reddy’s Laboratories Ltd ADR Stock

-₹1,776 (-1.78%)

Dollar Impact

₹12,801 (+12.8%)

Analyst Recommendation on Dr. Reddy’s Laboratories Ltd ADR Stock

Based on 40 analysts

BUY

42.50%

Buy

30.00%

Hold

27.50%

Sell

Based on 40 analysts, 42.5% of analysts recommend a 'BUY' rating for Dr. Reddy’s Laboratories Ltd ADR. Average target price of $14.21

Dr. Reddy’s Laboratories Ltd ADR Share Price Target

Get share price movements and forecasts by analysts on Dr. Reddy’s Laboratories Ltd ADR.

What analysts predicted

6.62%UPSIDE

Target Price

$14.21

Current Price

$13.27

Analyzed by

40 Analysts

Target

$14.21

Dr. Reddy’s Laboratories Ltd ADR target price $14.21, a slight upside of 6.62% compared to current price of $13.27. According to 40 analysts rating.

Dr. Reddy’s Laboratories Ltd ADR Stock’s Investor Sentiment and Interest

Investment in Dr. Reddy’s Laboratories Ltd ADR Shares on INDmoney has grown by 89.79% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:89.79% versus previous 30 day period

Search interest for Dr. Reddy’s Laboratories Ltd ADR Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:31% versus previous 30 day period

Dr. Reddy’s Laboratories Ltd ADR Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
10
866
852
919
956
983
983
85,452
88,051
87,268
Gross Profit
5
506
499
555
570
577
546
48,627
48,140
46,806
Operating Income
175
17,267
14,959
17,925
17,551
18,720
17,647
17,475
17,513
14,238
EBITDA
281
21,286
20,322
21,757
23,899
24,279
25,264
24,642
24,308
19,560
Interest Expense
353
394
593
598
757
818
656
830
907
951
Depreciation
3,789
3,770
3,713
3,810
3,975
4,719
4,554
4,765
5,051
5,213
Income Before Tax
231
18,257
16,016
18,821
19,167
18,742
20,054
19,047
18,350
15,429
Income Tax Expense
52
4,468
2,946
4,901
5,752
4,704
4,182
4,951
4,082
3,533
Net Income
2
165
157
166
149
166
184
14,178
14,372
12,098
Net Profit Margin
21.51%
19.11%
18.45%
18.14%
15.66%
16.91%
18.74%
16.59%
16.32%
13.86%

Dr. Reddy’s Laboratories Ltd ADR Annual Profit & Loss

All numbers in Millions USD

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
2,309
2,138
2,184
2,207
2,340
35
2,813
2,989
3,361
3,763
Gross Profit
1,377
1,189
1,173
1,196
1,260
17
1,493
1,694
1,970
2,201
Operating Income
29,619
13,498
11,917
20,888
15,993
431
29,476
57,144
67,729
71,843
EBITDA
39,869
24,775
23,627
35,522
41,785
534
45,080
74,431
88,422
96,671
Interest Expense
826
634
788
889
13
970
958
1,428
1,711
2,829
Depreciation
-
-
11,710
12,190
12,472
12,796
11,824
12,502
14,841
17,058
Income Before Tax
27,140
14,653
14,341
22,443
18,032
355
32,298
60,367
71,870
76,784
Income Tax Expense
7,127
2,614
4,535
3,648
-1,466
123
8,730
15,300
16,186
19,539
Net Income
298
182
150
269
261
3
309
548
670
653
Net Profit Margin
12.94%
8.55%
6.90%
12.22%
11.17%
9.09%
10.99%
18.33%
19.95%
17.37%

Dr. Reddy’s Laboratories Ltd ADR Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
13,789
157
13,920
13,415
14,038
15,872
14,096
14,268
11,897
Operating Cash Flow
4,737
136
8,496
9,316
6,620
21,996
14,629
15,573
10,908
Investing Cash Flow
-
-142
-20,248
-19,071
-5,458
-13,300
-19,192
-9,543
-10,292
Financing Cash Flow
5,282
1
9,541
16,150
590
-7,370
-1,203
-5,323
7,777
Change in Cash
-6,000
-5
-2,194
6,372
1,747
1,561
-5,589
902
8,751

Dr. Reddy’s Laboratories Ltd ADR Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
12,039
9,806
18,795
19,498
19,149
23,568
60,485
55,684
57,245
Operating Cash Flow
21,513
18,029
28,704
29,841
35,703
28,108
58,873
45,433
46,428
Investing Cash Flow
-18,471
-14,883
-7,727
-4,923
-22,660
-26,387
-41,373
-40,283
-58,077
Financing Cash Flow
-3,692
-4,440
-21,326
-25,159
-298
-2,422
-26,861
-3,763
18,911
Change in Cash
-1,142
-1,237
-314
-266
12,858
32
-9,073
1,328
7,486

Global Institutional Holdings in Dr. Reddy’s Laboratories Ltd ADR

Funds
Holdings
Geode Capital Management, LLC
0.16%
BlackRock Inc
1.24%
Royal Bank of Canada
1.15%
JPMorgan Chase & Co
0.66%
Jane Street Group LLC
0.14%
See all

Dr. Reddy’s Laboratories Ltd ADR News & Key Events

  • img

    Today's Timeline - 24 October

    Fri, 11:21 PM

    -

    Dr. Reddy's Laboratories reports stable Q3 2025 financials, reinforcing stakeholder confidence despite challenges in the U.S. generics market.

    Sat, 01:21 AM

    -

    Dr. Reddy's appoints Sanjay Sharma as new CHRO, effective December 1, 2025, following the resignation of Ms. Archana Bhaskar.

    Sat, 02:49 AM

    -

    Leadership changes at Dr. Reddy's lead to stock decline, despite stable financial results and strong market position.

Insights on Dr. Reddy’s Laboratories Ltd ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 171.4% return, outperforming this stock by 161.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 97.0% return, outperforming this stock by 98.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 88.05B → 87.26B (in $), with an average decrease of 0.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 14.37B → 12.09B (in $), with an average decrease of 15.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RDY stock has moved down by -2.8%

About Dr. Reddy’s Laboratories Ltd ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
OrganisationDr. Reddy’s Laboratories Ltd ADR
Headquarters8-2-337, Road No. 3, Hyderabad, India, 500034
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Erez Israeli M.B.A.
E-voting on sharesClick here to vote

Key Management of Dr. Reddy’s Laboratories Ltd ADR

Name

Title

Mr. Deepak Sapra M.B.A.

Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council

Mr. Motupalli Venkata Ramana M.B.A.

CEO of Global Generics & Member of Management Council

Mr. Patrick Aghanian B.A., M.B.A.

Head of Consumer Health Organization & Member of Management Council

Mr. Sushrut Kulkarni

Global Head of Integrated Product Development Organisation & Member of the Management Council

Mr. Kallam Satish Reddy B.Tech., M.S.

Chairman of the Board & Member of the Management Council

Mr. Erez Israeli M.B.A.

CEO & Member of the Management Council

Mr. Krishna K. Venkatesh B.Pharma M.S.

Global Head of IPDO, Integrated Product Development & Member of the Management Council

Mr. Sanjay Sharma B.Tech.

Executive VP, COO & Member of Management Council

Mr. Gunupati Venkateswara Prasad B.E.

Co-Chairman, MD & Member of Management Council

Mr. Mannam Venkatanarasimham

CFO & Member of the Management Council

FAQs

What is Dr. Reddy’s Laboratories Ltd ADR share price today?

Dr. Reddy’s Laboratories Ltd ADR share price today is $13.27 as on at the close of the market. Dr. Reddy’s Laboratories Ltd ADR share today touched a day high of $13.38 and a low of $13.21.

What is the 52 week high and 52 week low for Dr. Reddy’s Laboratories Ltd ADR share?

Dr. Reddy’s Laboratories Ltd ADR share touched a 52 week high of $16.17 on and a 52 week low of $12.77 on . Dr. Reddy’s Laboratories Ltd ADR stock price today i.e. is closed at $13.27,which is 17.93% down from its 52 week high and 3.92% up from its 52 week low.

What is Dr. Reddy’s Laboratories Ltd ADR's market capitalisation today?

Dr. Reddy’s Laboratories Ltd ADR market capitalisation is $0.01T as on .

How to invest in Dr. Reddy’s Laboratories Ltd ADR Stock (RDY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dr. Reddy’s Laboratories Ltd ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dr. Reddy’s Laboratories Ltd ADR Shares that will get you 0.1130 shares as per Dr. Reddy’s Laboratories Ltd ADR share price of $13.27 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Dr. Reddy’s Laboratories Ltd ADR Stock (RDY) from India?

Indian investors can start investing in Dr. Reddy’s Laboratories Ltd ADR (RDY) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Dr. Reddy’s Laboratories Ltd ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Dr. Reddy’s Laboratories Ltd ADR share’s latest price of $13.27 as on May 6, 2026 at 1:29 am IST, you will get 0.7536 shares of Dr. Reddy’s Laboratories Ltd ADR. Learn more about fractional shares .

What are the returns that Dr. Reddy’s Laboratories Ltd ADR has given to Indian investors in the last 5 years?

Dr. Reddy’s Laboratories Ltd ADR stock has given -5.57% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?